Genetic ablation of Pole4 in mice leads to a multifaceted disorder characterized by reduced growth, developmental abnormalities, lymphopenia, and increased lymphomagenesis, which resembles IMAGe syndrome in patients affected by hypomorphic mutations of POLE (Logan et al., 2018; Bellelli et al., 2018a). Here, POLE4 is linked to lymphopenia.